(MedPage Today) — After reviewing the positive findings in HER2-positive early-stage breast cancer from both DESTINY-Breast11 (DB-11) and DESTINY-Breast05 (DB-05) in an earlier video, investigator Erika Hamilton, MD, of the Sarah Cannon Research…
Source link : https://www.medpagetoday.com/meetingcoverage/esmovideopearls/118696
Author :
Publish date : 2025-11-25 15:15:00
Copyright for syndicated content belongs to the linked Source.
